In this Issue:
Artificial white-light vs. daylight PDT for AK
NMSC with aggressive subclinical extension in immunosuppressed patients
Challenges with pityriasis rubra pilaris
Baricitinib for moderate-to-severe psoriasis
Barrier creams against irritant contact dermatitis
Propranolol for infantile haemangioma does not impair growth/development
Clinical meaningfulness of complete skin clearance in psoriasis
Apremilast for palmoplantar psoriasis
Topical diclofenac/calcitriol for superficial and nodular BCCs
Cardiovascular risk in alopecia areata
Please login below to download this issue (PDF)